Search Results - Ryo Nishikawa

Refine Results
  1. 1
    Standard Therapy for Glioblastoma- A Review of Where We Are

    Standard Therapy for Glioblastoma- A Review of Where We Are by Ryo Nishikawa

    Published 2010
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients

    Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients by Minesh P. Mehta, Patrick Y. Wen, Ryo Nishikawa, David A. Reardon, Katherine B. Peters

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Spinal cord hemangioblastomas in von Hippel–Lindau disease

    Spinal cord hemangioblastomas in von Hippel–Lindau disease by Hiroshi Kanno, I. Yamamoto, Ryo Nishikawa, M Matsutani, Toshihiko Wakabayashi, Junji Yoshida, Nobuyuki Shitara, Ichiro Yamasaki, Taro Shuin

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.

    A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. by Ryo Nishikawa, Xiang-Dong Ji, R. Christopher Harmon, Cheri S. Lazar, Gordon N. Gill, Webster K. Cavenee, Hongyi Huang

    Published 1994
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Safety and efficacy of tumour-treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study

    Safety and efficacy of tumour-treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study by Ryo Nishikawa, Fumiyuki Yamasaki, Yoshiki Arakawa, Yoshihiro Muragaki, Yoshitaka Narita, Shota Tanaka, Shigeru Yamaguchi, Akitake Mukasa, Masayuki Kanamori

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy

    Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy by Frank Saran, Olivier Chinot, Roger Henriksson, Warren Mason, Wolfgang Wick, Timothy F. Cloughesy, Sunita Dhar, Emanuela Pozzi, Josep Garcia, Ryo Nishikawa

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma

    Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma by Wolfgang Wick, Olivier Chinot, Martin Bendszus, Warren Mason, Roger Henriksson, Frank Saran, Ryo Nishikawa, Cédric Révil, Yannick Kerloëguen, Timothy F. Cloughesy

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Up-Regulation of Angiopoietin-2, Matrix Metalloprotease-2, Membrane Type 1 Metalloprotease, and Laminin 5 γ 2 Correlates with the Invasiveness of Human Glioma

    Up-Regulation of Angiopoietin-2, Matrix Metalloprotease-2, Membrane Type 1 Metalloprotease, and Laminin 5 γ 2 Correlates with the Invasiveness of Human Glioma by Ping Guo, Yorihisa Imanishi, Frank C. Cackowski, Michael J. Jarzynka, Huo-Quan Tao, Ryo Nishikawa, Takanori Hirose, Bo Hu, Shi‐Yuan Cheng

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Significance of <i>IDH</i> mutations varies with tumor histology, grade, and genetics in Japanese glioma patients

    Significance of <i>IDH</i> mutations varies with tumor histology, grade, and genetics in Japanese glioma patients by Akitake Mukasa, Shunsaku Takayanagi, Kuniaki Saito, Junji Shibahara, Yusuke Tabei, Kazuhide Furuya, Takafumi Ide, Yoshitaka Narita, Ryo Nishikawa, Keisuke Ueki, Nobuhito Saito

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio

    Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio by Olivier Chinot, Ryo Nishikawa, Warren Mason, Roger Henriksson, Frank Saran, Timothy F. Cloughesy, Josep Garcia, Cédric Révil, Lauren E. Abrey, Wolfgang Wick

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway

    Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway by Bo Hu, Ping Guo, Ifat Bar-Joseph, Yorihisa Imanishi, Michael J. Jarzynka, Oliver Bögler, Tom Mikkelsen, Takanori Hirose, Ryo Nishikawa, Shi‐Yuan Cheng

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma

    Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma by Motoo Nagane, Ryo Nishikawa, Yusuke Narita, H. Kobayashi, Shingo Takano, Nobusada Shinoura, Taku Aoki, Keiji Sugiyama, J. Kuratsu, Yoshihiro Muragaki, Yasuo Sawamura, Masao Matsutani

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma

    Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma by Hajime Yonezawa, Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yasuhito Terui, Yoshiki Arakawa, Katsunori Asai, Noriko Fukuhara, Kazuhiko Sugiyama, Naoki Shinojima, Arata Aoi, Ryo Nishikawa

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Genome‐wide identification of genes with amplification and/or fusion in small cell lung cancer

    Genome‐wide identification of genes with amplification and/or fusion in small cell lung cancer by Reika Iwakawa, Masataka Takenaka, Takashi Kohno, Yoko Shimada, Yasushi Totoki, Tatsuhiro Shibata, Koji Tsuta, Ryo Nishikawa, Masayuki Noguchi, Aiko Sato‐Otsubo, Seishi Ogawa, Jun Yokota

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans

    SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans by Kun-Wei Liu, Haizhong Feng, Robert Bachoo, Andrius Kazlauskas, Erin Smith, Karen Symes, Ronald L. Hamilton, Motoo Nagane, Ryo Nishikawa, Bo Hu, Shi-Yuan Cheng

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling

    The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and... by Hongyi Huang, Motoo Nagane, Candice K. Klingbeil, Hong Lin, Ryo Nishikawa, Xiang-Dong Ji, Chun‐Ming Huang, Gordon N. Gill, H Wiley, Webster K. Cavenee

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    ELMO1 and Dock180, a Bipartite Rac1 Guanine Nucleotide Exchange Factor, Promote Human Glioma Cell Invasion

    ELMO1 and Dock180, a Bipartite Rac1 Guanine Nucleotide Exchange Factor, Promote Human Glioma Cell Invasion by Michael J. Jarzynka, Bo Hu, Kwok-Min Hui, Ifat Bar-Joseph, Weisong Gu, Takanori Hirose, Lisa B. Haney, Kodi S. Ravichandran, Ryo Nishikawa, Shi‐Yuan Cheng

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Using artificial intelligence to improve human performance: efficient retinal disease detection training with synthetic images

    Using artificial intelligence to improve human performance: efficient retinal disease detection training with synthetic images by Hitoshi Tabuchi, Justin Engelmann, Fumiatsu Maeda, Ryo Nishikawa, Toshihiko Nagasawa, Tomofusa Yamauchi, Mao Tanabe, Masahiro Akada, Keita Kihara, Yasuyuki Nakae, Yoshiaki Kiuchi, Miguel O. Bernabéu

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Phase I/II study of tirabrutinib, a second-generation Bruton’s tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma

    Phase I/II study of tirabrutinib, a second-generation Bruton’s tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma by Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yasuhito Terui, Yoshiki Arakawa, Hajime Yonezawa, Katsunori Asai, Noriko Fukuhara, Kazuhiko Sugiyama, Naoki Shinojima, Junsaku Kitagawa, Arata Aoi, Ryo Nishikawa

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    The safety and efficacy of preoperative embolization of meningioma with N-butyl cyanoacrylate

    The safety and efficacy of preoperative embolization of meningioma with N-butyl cyanoacrylate by Hideaki Ishihara, Shoichiro Ishihara, Jun Niimi, Hiroaki Neki, Yoshiaki Kakehi, Nahoko Uemiya, Shinya Kohyama, Fumitaka Yamane, Hiroshi Kato, Tomonari Suzuki, Jun-ichi Adachi, Kazuhiko Mishima, Ryo Nishikawa

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: